Climb Bio, Inc. (CLYM)
6.56
-0.39
(-5.61%)
USD |
NASDAQ |
Apr 02, 16:00
6.56
0.00 (0.00%)
After-Hours: 20:00
Climb Bio Total Liabilities (Quarterly) : 7.269M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 7.477B |
| Fortress Biotech, Inc. | 123.36M |
| Oramed Pharmaceuticals, Inc. | 31.12M |
| Lyell Immunopharma, Inc. | 91.85M |
| PepGen Inc. | 26.46M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 167.74M |
| Shareholders Equity (Quarterly) | 160.48M |
| Debt to Equity Ratio | 0.0034 |
| Current Ratio | 15.16 |
| Net Debt Paydown Yield | -0.05% |